HCSGD entry for TRIM32
1. General information
Official gene symbol | TRIM32 |
---|---|
Entrez ID | 22954 |
Gene full name | tripartite motif containing 32 |
Other gene symbols | BBS11 HT2A LGMD2H TATIP |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
![color bar](img/red_blue.jpg)
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000209 | Protein polyubiquitination | IDA | biological_process |
GO:0003713 | Transcription coactivator activity | TAS | molecular_function |
GO:0003723 | RNA binding | IEA ISS | molecular_function |
GO:0004842 | Ubiquitin-protein ligase activity | IDA IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IEA ISS | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0005829 | Cytosol | TAS | cellular_component |
GO:0005863 | Striated muscle myosin thick filament | IEA ISS | cellular_component |
GO:0008270 | Zinc ion binding | IEA | molecular_function |
GO:0009411 | Response to UV | IEA ISS | biological_process |
GO:0016567 | Protein ubiquitination | IDA | biological_process |
GO:0017022 | Myosin binding | IEA ISS | molecular_function |
GO:0030307 | Positive regulation of cell growth | IDA | biological_process |
GO:0030335 | Positive regulation of cell migration | IDA | biological_process |
GO:0030957 | Tat protein binding | TAS | molecular_function |
GO:0031369 | Translation initiation factor binding | IEA ISS | molecular_function |
GO:0032479 | Regulation of type I interferon production | TAS | biological_process |
GO:0032481 | Positive regulation of type I interferon production | TAS | biological_process |
GO:0034612 | Response to tumor necrosis factor | IEA ISS | biological_process |
GO:0042787 | Protein ubiquitination involved in ubiquitin-dependent protein catabolic process | IMP | biological_process |
GO:0043130 | Ubiquitin binding | IDA | molecular_function |
GO:0043621 | Protein self-association | IDA | molecular_function |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045444 | Fat cell differentiation | IEA ISS | biological_process |
GO:0045666 | Positive regulation of neuron differentiation | IEA ISS | biological_process |
GO:0045732 | Positive regulation of protein catabolic process | IEA ISS | biological_process |
GO:0045787 | Positive regulation of cell cycle | IDA | biological_process |
GO:0045862 | Positive regulation of proteolysis | IDA | biological_process |
GO:0048147 | Negative regulation of fibroblast proliferation | IEA ISS | biological_process |
GO:0050769 | Positive regulation of neurogenesis | IEA ISS | biological_process |
GO:0051092 | Positive regulation of NF-kappaB transcription factor activity | IEA ISS | biological_process |
GO:1902230 | Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | IDA | biological_process |
GO:2000147 | Positive regulation of cell motility | IEA ISS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0244307967 | 0.8432000114 | 0.3697761494 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.1240676352 |
GSE13712_SHEAR | Up | 0.1636868412 |
GSE13712_STATIC | Up | 0.3049019711 |
GSE19018 | Down | -0.4268622188 |
GSE19899_A1 | Up | 0.3308712881 |
GSE19899_A2 | Up | 1.1881307438 |
PubMed_21979375_A1 | Up | 1.3344160583 |
PubMed_21979375_A2 | Up | 2.0632220167 |
GSE35957 | Up | 0.1823804402 |
GSE36640 | Up | 0.2971548204 |
GSE54402 | Up | 0.0773199038 |
GSE9593 | Up | 0.0102667494 |
GSE43922 | Up | 0.3838412927 |
GSE24585 | Down | -0.0759409233 |
GSE37065 | Up | 0.1056811177 |
GSE28863_A1 | Up | 0.4104311124 |
GSE28863_A2 | Down | -0.0436413000 |
GSE28863_A3 | Down | -0.6488003911 |
GSE28863_A4 | Up | 0.0182752729 |
GSE48662 | Down | -0.1855292455 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-155-5p | MIMAT0000646 | MIRT001492 | pSILAC//Proteomics;Other | Functional MTI (Weak) | 18668040 |
hsa-miR-16-5p | MIMAT0000069 | MIRT031385 | Proteomics | Functional MTI (Weak) | 18668040 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 2 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
25701873 | Previously, we generated and characterized a Trim32 knockout mouse (T32KO) that displays both neurogenic and myopathic features |
25701873 | This satellite cell senescence is due to accumulation of the SUMO ligase PIASy, a substrate of TRIM32 |
25701873 | The goal of this investigation was to identify additional substrates of TRIM32 using 2D fluorescence difference gel electrophoresis (2D-DIGE) in order to further explore its role in skeletal muscle |
25701873 | Follow-up analysis confirmed that both proteins were ubiquitinated by TRIM32 in vitro; however, only NDRG2 accumulated in skeletal muscle and myoblasts in the absence of TRIM32 |
25701873 | Thus, we identified NDRG2 as a novel target for TRIM32; these findings further corroborate the hypothesis that TRIM32 is involved in control of myogenic cells proliferation and differentiation |
22505452 | Previously, we generated Trim32 knockout mice (Trim32-/- mice) and showed that they display a myopathic phenotype accompanied by neurogenic features |
22505452 | Here, we used these mice to investigate the muscle-specific defects arising from the absence of TRIM32, which underlie the myopathic phenotype |
22505452 | Using 2 models of induced atrophy, we showed that TRIM32 is dispensable for muscle atrophy |
22505452 | Conversely, TRIM32 was necessary for muscle regrowth after atrophy |
22505452 | Furthermore, TRIM32-deficient primary myoblasts underwent premature senescence and impaired myogenesis due to accumulation of PIAS4, an E3 SUMO ligase and TRIM32 substrate that was previously shown to be associated with senescence |
22505452 | Trim32-/- muscles had substantially fewer activated satellite cells, increased PIAS4 levels, and growth failure compared with wild-type muscles |
22505452 | Moreover, Trim32-/- muscles exhibited features of premature sarcopenia, such as selective type II fast fiber atrophy |
22505452 | These results imply that premature senescence of muscle satellite cells is an underlying pathogenic feature of LGMD2H and reveal what we believe to be a new mechanism of muscular dystrophy associated with reductions in available satellite cells and premature sarcopenia |
Entries Per Page
Displaying Page of